Advanced Enzyme Technologies Ltd.
ADVENZYMES Share PricePharmaceuticals & Drugs
₹346
5.8 (1.7%)
As on September 8, 2025
Exchange Scrips: BSE540025NSEADVENZYMESISININE837H01020
Market Cap ₹ 3,845 Cr
P/E Ratio 29.52
Dividend Yield 0.75 %
Performance
Market performance
Open341.35
High352
Volumes2,32,611
Prev346
Low338.45
As on2025-09-08
Historical performance
1 Year High571
3 Year High571
5 Year High571
1 Year Low257.9
3 Year Low225
5 Year Low216.7
Fundamentals
Company Valuation
Market Cap (₹Cr)
3,845
Face Value (₹)
2
P/E Ratio
29.52
Dividend Yield
0.75 %
Investment Returns
1 Year
-24.2%
3 Years
25.6%
5 Years
50.5%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 341.71 | Bullish |
| 10-DMA | 332.83 | Bullish |
| 20-DMA | 320.08 | Bullish |
| 50-DMA | 326.98 | Bullish |
| 100-DMA | 315.21 | Bullish |
| 200-DMA | 320.69 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 14 | 14 | 11 | 11 | 7 |
| Foreign Investors | 5 | 5 | 5 | 5 | 5 |
| Domestic Investors | 9 | 9 | 6 | 6 | 2 |
| Public Investors | 67575 | 65308 | 67340 | 66747 | 65215 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 29.52.
- 3Y Stock Price CAGR of the stock is 7.8.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹2286 Million.
- The company generated revenue of ₹6369 Million in the previous financial year.
Advanced Enzyme Technologies Ltd.
3465.8 (1.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 769658.5
No. of Shares: 2224 (Approx)
Performance:-23%
P/L: ₹-230341.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent